NCT06734078Active, not recruiting
An Italian Multicenter Retrospective Observational Study to Assess the Clinical Characteristics and the Outcome of Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma Treated With Polatuzumab Vedotin Plus Rituximab (± Bendamustine) Under Named Patient Programme
Source: ClinicalTrials.gov · Last updated 29 Jan 2025
Brief summary (registry, in English)
Study designobservational, non-interventional, retrospective, multicenter study.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 100 (actual)
- First submitted
- 1 Dec 2024
- Start date
- 20 May 2021
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Diseases
- Diffuse large B-cell lymphoma
- NCT number
- NCT06734078
What you commit to
- Study type: Observational
- Participants enrolled: 100
- From 20 May 2021 to the primary completion date, 31 Dec 2025
- 9 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with DLBCL treated with polatuzumab vedotin plus rituximab (± bendamustine) within a clinical trial context
Who the study is looking for
- Patients with relapsed or refractory DLBCL who received at least 1 dose of polatuzumab vedotin under the NPP (D.M. 7 Sep 2017) in the period between June 2019 and Feb 2020 in Italy.
- Age ≥ 18 years at enrolment.
- Written informed consent (if applicable).
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (9)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Azienda Ospedaliera Universitaria- Policlinico di Bari Coordinator of this site? Confirm its status | Bari | Italy | Unknown status |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna Coordinator of this site? Confirm its status | Bologna | Italy | Unknown status |
| Ospedale Oncologico Armando Businco Coordinator of this site? Confirm its status | Cagliari | Italy | Unknown status |
| Ospedale Maggiore della Carità Coordinator of this site? Confirm its status | Novara | Italy | Unknown status |
| Azienda Ospedaliera Ospedali Riuniti Villa Sofia - Cervello Coordinator of this site? Confirm its status | Palermo | Italy | Unknown status |
| CORE IRCCS Arcispedale Santa Maria Nuova Coordinator of this site? Confirm its status | Reggio Emilia | Italy | Unknown status |
| Casa Sollievo della Sofferenza - Reparto di Oncoematologia Coordinator of this site? Confirm its status | San Giovanni Rotondo | Italy | Unknown status |
| Azienda Ospedaliera Santa Maria - SC di Oncoematologia Coordinator of this site? Confirm its status | Terni | Italy | Unknown status |
| ULSS2 - Ospedale Civile Ca' Foncello - UO Ematologia Coordinator of this site? Confirm its status | Treviso | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.